STOCK TITAN

P3 Health Partners Names Leif Pedersen New Chief Financial Officer

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

P3 Health Partners (NASDAQ: PIII) has announced the appointment of Leif Pedersen as its new Chief Financial Officer, effective October 1, 2024. Pedersen, with over 25 years of experience in finance and value-based care, will succeed Atul Kavthekar, who will transition to a Strategic Advisor role. Pedersen's background includes serving as VP of Finance & CFO Shared Services at Optum Health and VP of Finance & CFO IT at DaVita Medical Group.

In his new role, Pedersen will oversee Accounting, Treasury, Finance Analytics, and Investor Relations. P3's CEO, Dr. Aric Coffman, expressed confidence in Pedersen's ability to help the company achieve its long-term goals while maintaining excellence in value-based care.

P3 Health Partners (NASDAQ: PIII) ha annunciato la nomina di Leif Pedersen come nuovo Chief Financial Officer, con effetto dal 1 ottobre 2024. Pedersen, con oltre 25 anni di esperienza nel settore finanziario e nella cura basata sul valore, succederà ad Atul Kavthekar, che passerà a un ruolo di Consulente Strategico. Il background di Pedersen include il ruolo di VP Finance & CFO Shared Services presso Optum Health e VP Finance & CFO IT presso DaVita Medical Group.

Nel suo nuovo incarico, Pedersen supervisionerà Contabilità, Tesoreria, Analisi Finanziaria e Relazioni con gli Investitori. Il CEO di P3, Dr. Aric Coffman, ha espresso fiducia nella capacità di Pedersen di aiutare l'azienda a raggiungere i suoi obiettivi a lungo termine mantenendo l'eccellenza nella cura basata sul valore.

P3 Health Partners (NASDAQ: PIII) ha anunciado el nombramiento de Leif Pedersen como su nuevo Director Financiero, efectivo a partir del 1 de octubre de 2024. Pedersen, con más de 25 años de experiencia en finanzas y atención basada en el valor, sucederá a Atul Kavthekar, quien pasará a un rol de Asesor Estratégico. La experiencia de Pedersen incluye haber sido VP de Finanzas y CFO de Servicios Compartidos en Optum Health y VP de Finanzas y CFO de IT en DaVita Medical Group.

En su nuevo rol, Pedersen supervisará Contabilidad, Tesorería, Análisis Financiero y Relaciones con Inversores. El CEO de P3, Dr. Aric Coffman, expresó confianza en la capacidad de Pedersen para ayudar a la empresa a alcanzar sus objetivos a largo plazo mientras mantiene la excelencia en la atención basada en el valor.

P3 Health Partners (NASDAQ: PIII)는 Leif Pedersen를 새로운 최고재무책임자로 임명했다고 발표했으며, 이는 2024년 10월 1일부터 시행됩니다. Pedersen은 25년 이상의 재무 및 가치 기반 의료 경험을 가지고 있으며, Atul Kavthekar의 후임자로 임명되었습니다. Kavthekar는 전략 고문 역할로 전환할 예정입니다. Pedersen의 경력에는 Optum Health에서 재무 부사장 및 CFO 공유 서비스, DaVita Medical Group에서 IT 재무 부사장 및 CFO의 역할이 포함됩니다.

Pedersen은 새로운 역할에서 회계, 재무, 재무 분석 및 투자자 관계를 감독하게 됩니다. P3의 CEO인 Dr. Aric Coffman은 Pedersen이 회사가 장기적인 목표를 달성하고 가치 기반 의료에서의 우수성을 유지하는 데 도움을 줄 것이라고 확신한다고 전했습니다.

P3 Health Partners (NASDAQ: PIII) a annoncé la nomination de Leif Pedersen en tant que nouveau Directeur Financier, prenant effet le 1er octobre 2024. Pedersen, avec plus de 25 ans d'expérience dans le domaine financier et des soins basés sur la valeur, succédera à Atul Kavthekar, qui passera à un rôle de Conseiller Stratégique. Le parcours de Pedersen inclut des postes en tant que VP Finance & CFO Shared Services chez Optum Health et VP Finance & CFO IT chez DaVita Medical Group.

Dans son nouveau rôle, Pedersen supervisera la comptabilité, la trésorerie, l'analyse financière et les relations avec les investisseurs. Le PDG de P3, Dr. Aric Coffman, a exprimé sa confiance dans la capacité de Pedersen à aider l'entreprise à atteindre ses objectifs à long terme tout en maintenant l'excellence dans les soins basés sur la valeur.

P3 Health Partners (NASDAQ: PIII) hat die Ernennung von Leif Pedersen zum neuen Chief Financial Officer bekannt gegeben, die am 1. Oktober 2024 in Kraft tritt. Pedersen, der über 25 Jahre Erfahrung im Finanzwesen und in der wertbasierten Versorgung verfügt, wird Atul Kavthekar nachfolgen, der in eine Rolle als Strategischer Berater wechselt. Pedersens Hintergrund umfasst die Tätigkeit als VP Finance & CFO Shared Services bei Optum Health und VP Finance & CFO IT bei DaVita Medical Group.

In seiner neuen Rolle wird Pedersen die Bereiche Rechnungswesen, Treasury, Finanzanalyse und Investor Relations leiten. Der CEO von P3, Dr. Aric Coffman, äußerte sich zuversichtlich, dass Pedersen dem Unternehmen helfen wird, seine langfristigen Ziele zu erreichen und dabei Exzellenz in der wertbasierten Versorgung sicherzustellen.

Positive
  • Appointment of experienced CFO with 25+ years in finance and value-based care
  • New CFO has relevant experience from major healthcare companies (Optum Health, DaVita Medical Group)
  • Smooth transition plan with current CFO becoming Strategic Advisor
Negative
  • None.

HENDERSON, Nev.--(BUSINESS WIRE)-- P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, announced today that Leif Pedersen, an experienced finance, operational and value-based care executive, will join the company as chief financial officer (CFO) effective October 1, 2024. Pedersen succeeds Atul Kavthekar, who will continue as CFO until September 30, 2024, after which he will serve as a Strategic Advisor to the company.

Pedersen was most recently Vice President of Finance & CFO Shared Services for Optum Health, a division of UnitedHealth Group. Prior to Optum Health, Pedersen served as Vice President of Finance & CFO IT at DaVita Medical Group. He brings more than 25 years of experience within large-scale, publicly traded organizations including 9 years in value-based care and 6 years of “Big Four” public accounting. In his new role, Pedersen will oversee Accounting, Treasury, Finance Analytics, and Investor Relations.

"I am pleased to announce Leif’s appointment as P3’s next CFO," said Dr. Aric Coffman, CEO of P3 Health Partners. "Our team has worked with Leif over many years, and his strong background in value-based care makes him an ideal CFO. With Leif’s leadership, P3 is well-positioned to achieve our long term goals while upholding our commitment to excellence in value-based care. We also extend our deepest thanks to Atul for his invaluable contribution and are grateful for his continued support at P3 in an advisory role."

"I am honored to join P3 as CFO at this exciting time," said Leif Pedersen, incoming CFO, P3 Health Partners. "P3 is a leader in value-based care, and I look forward to building on the strong foundation already in place. My focus will be on driving operational excellence, enhancing value across stakeholders, and supporting the company’s mission to deliver high-quality, cost-effective care. I am eager to collaborate with the talented team at P3 to achieve our strategic goals, and contribute to the company’s continued success and growth."

About P3 Health Partners

P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the lives of both patients and providers. Founded and led by physicians, P3 has an expansive network of more than 2,900 affiliated primary care providers across the country. Our local teams of health care professionals manage the care of thousands of patients in 27 counties across five states. P3 supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, the P3 care team creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. For more information, visit www.p3hp.org and follow us on LinkedIn and Facebook.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "envision," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "project," "seek," "should," "target," or "will," or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected or estimated and you are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.

Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, our ability to continue as a going concern; our potential need to raise additional capital to fund our existing operations or develop and commercialize new services or expand our operations; our ability to achieve or maintain profitability; our ability to maintain compliance with our debt covenants in the future, or obtain required waivers from our lenders if future operating performance were to fall below current projections, and if there are material changes to management’s assumptions, we could be required to recognize non-cash charges to operating earnings for goodwill and/or other intangible asset impairment; our ability to identify and develop successful new geographies, physician partners, payors and patients; changes in market or industry conditions, regulatory environment, competitive conditions, and receptivity to our services; our ability to fund our growth and expand our operations; changes in laws and regulations applicable to our business; our ability to maintain our relationships with health plans and other key payors; our ability to establish and maintain effective internal controls and the impact of the material weaknesses we have identified; our ability to maintain the listing of our securities on The Nasdaq Stock Market, LLC; increased labor costs; our ability to recruit and retain qualified team members and independent physicians; and the factors described under Part I, Item 1A. “Risk Factors” and Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 28, 2024, and in our subsequent filings with the SEC.

All information in this press release is as of the date hereof, and we undertake no duty to update or revise this information unless required by law. You are cautioned not to place undue reliance on any forward-looking statements contained in this press release.

Ryan Halsted

Investor Relations

Gilmartin Group

investors@p3hp.org

Source: P3 Health Partners Inc.

FAQ

Who is the new CFO of P3 Health Partners (PIII)?

Leif Pedersen has been named the new Chief Financial Officer of P3 Health Partners (NASDAQ: PIII), effective October 1, 2024.

What is Leif Pedersen's background before joining P3 Health Partners (PIII)?

Leif Pedersen was previously Vice President of Finance & CFO Shared Services for Optum Health and Vice President of Finance & CFO IT at DaVita Medical Group. He has over 25 years of experience in finance and value-based care.

When will Leif Pedersen start as CFO of P3 Health Partners (PIII)?

Leif Pedersen will start as Chief Financial Officer of P3 Health Partners (NASDAQ: PIII) on October 1, 2024.

What will happen to the current CFO of P3 Health Partners (PIII)?

The current CFO, Atul Kavthekar, will continue in his role until September 30, 2024, after which he will serve as a Strategic Advisor to P3 Health Partners (NASDAQ: PIII).

P3 Health Partners Inc.

NASDAQ:PIII

PIII Rankings

PIII Latest News

PIII Stock Data

31.06M
126.16M
23.2%
24.99%
0.59%
Medical Care Facilities
Services-health Services
Link
United States of America
CHICAGO